Advertisement
The U.S. Food and Drug Administration has issued a warning that injectable skin-lightening products are potentially unsafe and ineffective.

FDA Issues Warning Regarding Injectable Skin Lighteners

0
Injectable products may contain unknown substances or contaminants
None of 657 patients who took a daily pill to prevent HIV infection contracted the virus over a period of more than two years

Daily PrEP Prevents HIV Infection in High-Risk Individuals

0
Study participants were infected with other sexually transmitted diseases
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
For patients with diabetic nephropathy receiving an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker

Finerenone Linked to Improved UACR in Diabetic Nephropathy

0
Addition of finerenone to ACE inhibitor or ARB tied to reduction in urinary albumin-creatinine ratio
For patients with rheumatoid arthritis with prior biologic exposure

Study Compares Hospitalized Infection Risk for Biologics in RA

0
Risk of hospitalized infection increased with etanercept, infliximab, rituximab versus abatacept
Many adolescents with chronic diseases such as asthma and juvenile arthritis have consumed alcohol or smoked marijuana in the last year

Many Teens With Chronic Illnesses Use Alcohol, Marijuana

0
Four out of 10 high school students with medical conditions used one or both in past year
For patients with established Chagas' cardiomyopathy

Benznidazole Tx Explored in Chagas’ Cardiomyopathy

0
Reduces serum parasite detection but does not reduce cardiac clinical deterioration through 5 years
For patients with an acute coronary syndrome undergoing percutaneous coronary intervention

Bivalirudin Doesn’t Lower Major Cardiovascular Event Rate in ACS

0
No decrease in rate of major CV events, net adverse clinical events for patients undergoing PCI

August 2015 Briefing – Pharmacy

0
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for August 2015. This roundup includes the latest...
In patients with newly diagnosed multiple myeloma

Continuous Therapy Improves Survival in Multiple Myeloma

0
Benefit seen in progression-free, overall survival compared with fixed duration of therapy